Revvity (RVTY) Accumulated Expenses (2010 - 2026)
Revvity's (RVTY) quarterly Accumulated Expenses came in at $538.5 million in Q3 2026, up 9.13% on a YoY basis from $493.4 million in Q3 2025, and up 9.19% quarter-over-quarter from $493.1 million in Q2 2026.
Analysis
Revvity (RVTY) Accumulated Expenses (2010 - 2026) Analysis & Trends
Revvity (RVTY) has reported Accumulated Expenses for 17 consecutive years, with $538.5 million the latest figure, recorded in Q3 2026.
- For the quarter ending Q3 2026, Accumulated Expenses rose 9.13% year-over-year to $538.5 million; the trailing twelve-month figure through Jul 2026 stood at $538.5 million (up 9.13% YoY), and the FY2025 full-year result was $557.0 million, up 14.74% from the prior year.
- Accumulated Expenses climbed to $538.5 million in Q3 2026 per RVTY's latest filing, from $493.1 million in the prior quarter.
- Across five years, Accumulated Expenses topped out at $882.6 million in Q2 2022 and bottomed at $463.1 million in Q3 2025.
- Historically, Accumulated Expenses has averaged $567.7 million across 5 years, with a median of $524.5 million in 2023.
- The sharpest annual moves came in 2022 and 2025: Accumulated Expenses slumped 42.5% in 2022, then gained 14.74% in 2025.
- Over 5 years, Accumulated Expenses stood at $471.6 million in 2022, then advanced by 11.22% to $524.5 million in 2023, then dropped by 7.45% to $485.4 million in 2024, then increased by 14.74% to $557.0 million in 2025, then fell by 3.32% to $538.5 million in 2026.
- According to Business Quant data, Accumulated Expenses over the past three periods registered $538.5 million, $493.1 million, and $557.0 million for Q3 2026, Q2 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 5, 2026 | 538.46 Mn |
| Apr 5, 2026 | 493.13 Mn |
| Dec 28, 2025 | 556.95 Mn |
| Sep 28, 2025 | 463.10 Mn |
| Jun 29, 2025 | 493.43 Mn |
| Mar 30, 2025 | 469.86 Mn |
| Dec 29, 2024 | 485.40 Mn |
| Sep 29, 2024 | 510.49 Mn |
| Jun 30, 2024 | 503.73 Mn |
| Mar 31, 2024 | 479.25 Mn |
| Dec 31, 2023 | 524.47 Mn |
| Oct 1, 2023 | 532.00 Mn |
| Jul 2, 2023 | 652.17 Mn |
| Apr 2, 2023 | 817.43 Mn |
| Jan 1, 2023 | 527.86 Mn |
| Oct 2, 2022 | 471.57 Mn |
| Jul 3, 2022 | 705.92 Mn |
| Apr 3, 2022 | 882.63 Mn |
| Jan 2, 2022 | 679.10 Mn |
| Oct 3, 2021 | 820.11 Mn |